Refractory, severe hidradenitis suppurativa Hurley stage III shows positive response to a therapy with the combination of brodalumab (Il-17-receptor-inhibitor) and Upadacitinib (JAK - inhibitor). A case report
EXPERIMENTAL DERMATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要